Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10254966 | 0.75 | EPHX1 (0.46) | EPHX1 | |
| SCHEMBL1172663 | 0.74 | — | — | |
| SCHEMBL712650 | 0.74 | EPHX1 (0.33) | EPHX1 | |
| SCHEMBL19747704 | 0.74 | — | — | |
| SCHEMBL21356700 | 0.72 | — | — | |
| SCHEMBL9429767 | 0.67 | — | — | |
| SCHEMBL3810403 | 0.67 | — | — | |
| SCHEMBL627879 | 0.67 | — | — | |
| SCHEMBL5310995 | 0.67 | — | — | |
| SCHEMBL17826043 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 197 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5354495-A | Homo- or copolymerizable through ethylenic unsaturation | NIPPON PAINT CO., LTD. (JP) | 1994-10-11 | — | — | US | claimed |
| EP-0177122-B1 | ACRYLAMIDE DERIVATIVES | Nippon Paint Co., Ltd. (JP) | 1992-04-01 | — | — | EP | claimed |
| US-4935413-A | ELASTICITY, ADHESION AND DISPERSIBILITY | NIPPON PAINT CO., LTD. (JP) | 1990-06-19 | — | — | US | claimed |
| US-4425473-A | 2,6,7-TRIOXABICYCLO(2.2.2)OCTANES, VOLUME EXPANSION, NONSHRINKING | TOAGOSEI CHEMICAL INDUSTRY CO., LTD. (JP) | 1984-01-10 | — | — | US | claimed |
| JP-60233114-A | — | — | None | — | — | JP | disclosed |
| EP-4282857-B1 | RADIOACTIVE HALOGEN-LABELED PRECURSOR COMPOUND | INST OF SCIENCE TOKYO (JP) | 2026-04-15 | — | — | EP | disclosed |
| WO-2025023235-A1 | BRANCHED MULTI-HYDROXYL-PROTECTING OLIGOMER, LINKED BODY BONDED THEREWITH, AND BRANCHED MULTI-HYDROXYL OLIGOMER OBTAINED BY DEPROTECTING SAID LINKED BODY | トモイケ バイオ リミテッド | 2025-01-30 | — | — | WO | disclosed |
| US-20240173305-A1 | RAPAMYCIN ANALOGS AND USES THEREOF | JANSSEN PHARMACEUTICA NV (BE) | 2024-05-30 | — | — | US | disclosed |
| EP-3813946-B1 | RAPAMYCIN ANALOGS AND USES THEREOF | JANSSEN PHARMACEUTICA NV (BE) | 2024-05-22 | — | — | EP | disclosed |
| CN-117843659-A | Rapamycin analogues and uses thereof | 詹森药业有限公司 | 2024-04-09 | — | — | CN | disclosed |
| US-11944605-B2 | Rapamycin analogs and uses thereof | JANSSEN PHARMACEUTICA NV (BE) | 2024-04-02 | — | — | US | disclosed |
| US-20240034721-A1 | RADIOACTIVE HALOGEN LABELING PRECURSOR COMPOUND | TOKYO INSTITUTE OF TECHNOLOGY (JP) | 2024-02-01 | — | — | US | disclosed |
| EP-0207621-A2 | Functional polymers and their production | Nippon Paint Co., Ltd. (JP) | 1987-01-07 | — | — | EP | disclosed |
| EP-0177122-A2 | Acrylamide derivatives | Nippon Paint Co., Ltd. (JP) | 1986-04-09 | — | — | EP | disclosed |
| JP-S60233114-A | CROSSLINKED POLYMER | MITSUI TOATSU CHEM INC | 1985-11-19 | — | — | JP | disclosed |
| US-4529786-A | Acrylate and methacrylate monoesters of pentaerythritol and pentaerythritol orthoesters and polymers and copolymers derived therefrom | CELANESE CORPORATION (US) | 1985-07-16 | — | — | US | disclosed |
| US-4526949-A | Vinyl acrylic copolymer incorporating alpha, beta-ethylenically unsaturated monoester | CELANESE CORPORATION (US) | 1985-07-02 | — | — | US | disclosed |
| US-4425473-A | 2,6,7-TRIOXABICYCLO(2.2.2)OCTANES, VOLUME EXPANSION, NONSHRINKING | TOAGOSEI CHEMICAL INDUSTRY CO., LTD. (JP) | 1984-01-10 | — | — | US | disclosed |
| US-4405798-A | CHEMICAL INTERMEDIATES | CELANESE CORPORATION (US) | 1983-09-20 | — | — | US | disclosed |
| US-4338240-A | Curable material and process for production thereof | TOAGOESI CHEMICAL INDUSTRY CO., LTD. (JP) | 1982-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240034721-A1 | RADIOACTIVE HALOGEN LABELING PRECURSOR COMPOUND | GPR119, SLC5A2, GCKR | EPHX1 4137/4885 |
| US-11944605-B2 | Rapamycin analogs and uses thereof | RICTOR, MTOR, RPTOR | EPHX1 4663/4885 |
| US-20240173305-A1 | RAPAMYCIN ANALOGS AND USES THEREOF | RICTOR, MTOR, RPTOR | EPHX1 4663/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.